Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation

ClinicalTrials.gov ID: NCT03339401

Public ClinicalTrials.gov record NCT03339401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir Versus Standard of Care for Treatment of Adenovirus in High-risk Pediatric Allogeneic Hematopoietic Transplant Recipients

Study identification

NCT ID
NCT03339401
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
29 participants

Conditions and interventions

Conditions

Interventions

  • Standard of Care Other
  • Brincidofovir Drug

Other · Drug

Eligibility (public fields only)

Age range
2 Months to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2017
Primary completion
May 9, 2019
Completion
May 9, 2019
Last update posted
Jan 24, 2021

2017 – 2019

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Children's Hospital of Los Angeles Los Angeles California 90027
University of California San Francisco San Francisco California 94143
University of Chicago Chicago Illinois 60637
Joseph M. Sanzari Childrens Hospital-Regional Cancer Care Hackensack New Jersey 07601
Memorial Sloan Kettering Cancer Center New York New York 10065
Duke University Medical Center Durham North Carolina 27705
Cincinnati Childrens Hospital Medical Center Cincinnati Ohio 45229
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
St. Jude Children's Research Hospital Memphis Tennessee 38105
University of Washington-Seattle Childrens Hospital Seattle Washington 98105
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03339401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03339401 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →